Pontifax Management 4 G.P. (2015) Ltd.

Insider Buys Quantity –
2
2020-11-17PurchaseKeros Therapeutics, Inc.
KROS
10 percent owner
120,000
0.5794%
$50.00$6M-19.24%
2020-04-13PurchaseKeros Therapeutics, Inc.
KROS
10 percent owner
874,998
3.4196%
$16.00$14M+122.73%